PMID- 37740796 OWN - NLM STAT- MEDLINE DCOM- 20230925 LR - 20231011 IS - 1420-9071 (Electronic) IS - 1420-682X (Linking) VI - 80 IP - 10 DP - 2023 Sep 23 TI - FKBP5 deficiency attenuates calcium oxalate kidney stone formation by suppressing cell-crystal adhesion, apoptosis and macrophage M1 polarization via inhibition of NF-kappaB signaling. PG - 301 LID - 10.1007/s00018-023-04958-7 [doi] AB - Surgical crushing of stones alone has not addressed the increasing prevalence of kidney stones. A promising strategy is to tackle the kidney damage and crystal aggregation inherent in kidney stones with the appropriate therapeutic target. FKBP prolyl isomerase 5 (FKBP5) is a potential predictor of kidney injury, but its status in calcium oxalate (CaOx) kidney stones is not clear. This study attempted to elucidate the role and mechanism of FKBP5 in CaOx kidney stones. Lentivirus and adeno-associated virus were used to control FKBP5 expression in a CaOx kidney stone model. Transcriptomic sequencing and immunological assays were used to analyze the mechanism of FKBP5 deficiency in CaOx kidney stones. The results showed that FKBP5 deficiency reduced renal tubular epithelial cells (RTEC) apoptosis and promoted cell proliferation by downregulating BOK expression. It also attenuated cell-crystal adhesion by downregulating the expression of CDH4. In addition, it inhibited M1 polarization and chemotaxis of macrophages by suppressing CXCL10 expression in RTEC. Moreover, the above therapeutic effects were exerted by inhibiting the activation of NF-kappaB signaling. Finally, in vivo experiments showed that FKBP5 deficiency attenuated stone aggregation and kidney injury in mice. In conclusion, this study reveals that FKBP5 deficiency attenuates cell-crystal adhesion, reduces apoptosis, promotes cell proliferation, and inhibits macrophage M1 polarization and chemotaxis by inhibiting NF-kappaB signaling. This provides a potential therapeutic target for CaOx kidney stones. CI - (c) 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG. FAU - Song, Qianlin AU - Song Q AD - Department of Urology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, Hubei, People's Republic of China. AD - Central Laboratory, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, Hubei, People's Republic of China. FAU - Song, Chao AU - Song C AD - Department of Urology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, Hubei, People's Republic of China. FAU - Chen, Xin AU - Chen X AUID- ORCID: 0000-0003-3885-4944 AD - Central Laboratory, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, Hubei, People's Republic of China. drxinchen@whu.edu.cn. AD - Reproductive Medical Center, Renmin Hospital of Wuhan University and Hubei Clinic Research Center for Assisted Reproductive Technology and Embryonic Development, Jiefang Road 238, Wuhan, 430060, Hubei, People's Republic of China. drxinchen@whu.edu.cn. FAU - Xiong, Yunhe AU - Xiong Y AD - Department of Urology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, Hubei, People's Republic of China. FAU - Li, Lijun AU - Li L AD - School of Power and Mechanical Engineering, The Institute of Technological Science, Wuhan University, South Donghu Road 8, Wuhan, 430072, Hubei, People's Republic of China. FAU - Liao, Wenbiao AU - Liao W AD - Department of Urology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, Hubei, People's Republic of China. FAU - Xue, Longjian AU - Xue L AD - School of Power and Mechanical Engineering, The Institute of Technological Science, Wuhan University, South Donghu Road 8, Wuhan, 430072, Hubei, People's Republic of China. xuelongjian@whu.edu.cn. FAU - Yang, Sixing AU - Yang S AD - Department of Urology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, Hubei, People's Republic of China. sxyang@whu.edu.cn. LA - eng GR - 82070723/National Natural Science Foundation of China/ GR - 82270797/National Natural Science Foundation of China/ PT - Journal Article DEP - 20230923 PL - Switzerland TA - Cell Mol Life Sci JT - Cellular and molecular life sciences : CMLS JID - 9705402 RN - 0 (NF-kappa B) RN - 2612HC57YE (Calcium Oxalate) RN - Nephrolithiasis, Calcium Oxalate SB - IM MH - Animals MH - Mice MH - *NF-kappa B MH - Calcium Oxalate MH - Signal Transduction MH - *Kidney Calculi/genetics MH - Apoptosis OTO - NOTNLM OT - Cell-crystal adhesion OT - FKBP5 OT - Immune regulation OT - Kidney stones OT - NF-kappaB signaling EDAT- 2023/09/23 20:42 MHDA- 2023/09/25 06:42 CRDT- 2023/09/23 11:06 PHST- 2023/07/12 00:00 [received] PHST- 2023/09/08 00:00 [accepted] PHST- 2023/09/07 00:00 [revised] PHST- 2023/09/25 06:42 [medline] PHST- 2023/09/23 20:42 [pubmed] PHST- 2023/09/23 11:06 [entrez] AID - 10.1007/s00018-023-04958-7 [pii] AID - 10.1007/s00018-023-04958-7 [doi] PST - epublish SO - Cell Mol Life Sci. 2023 Sep 23;80(10):301. doi: 10.1007/s00018-023-04958-7.